Literature DB >> 34218225

Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.

April Zhang1, Hira Aslam1, Neha Sharma1, Aryeh Warmflash2, Walid D Fakhouri1,3.   

Abstract

Epithelial to mesenchymal transition (EMT) is a highly conserved cellular process in several species, from worms to humans. EMT plays a fundamental role in early embryogenesis, wound healing, and cancer metastasis. For neural crest cell (NCC) development, EMT typically results in forming a migratory and potent cell population that generates a wide variety of cell and tissue, including cartilage, bone, connective tissue, endocrine cells, neurons, and glia amongst many others. The degree of conservation between the signaling pathways that regulate EMT during development and metastatic cancer (MC) has not been fully established, despite ample studies. This systematic review and meta-analysis dissects the major signaling pathways involved in EMT of NCC development and MC to unravel the similarities and differences. While the FGF, TGFβ/BMP, SHH, and NOTCH pathways have been rigorously investigated in both systems, the EGF, IGF, HIPPO, Factor Receptor Superfamily, and their intracellular signaling cascades need to be the focus of future NCC studies. In general, meta-analyses of the associated signaling pathways show a significant number of overlapping genes (particularly ligands, transcription regulators, and targeted cadherins) involved in each signaling pathway of both systems without stratification by body segments and cancer type. Lack of stratification makes it difficult to meaningfully evaluate the intracellular downstream effectors of each signaling pathway. Finally, pediatric neuroblastoma and melanoma are NCC-derived malignancies, which emphasize the importance of uncovering the EMT events that convert NCC into treatment-resistant malignant cells.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Cell fate; Delamination; Disease; Embryogenesis; Induction; Migration; Multipotency

Mesh:

Substances:

Year:  2021        PMID: 34218225      PMCID: PMC8387394          DOI: 10.1159/000516466

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.208


  279 in total

1.  Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration.

Authors:  C LaBonne; M Bronner-Fraser
Journal:  Dev Biol       Date:  2000-05-01       Impact factor: 3.582

2.  TGFbeta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development.

Authors:  Tomoyo Sasaki; Yoshihiro Ito; Pablo Bringas; Stanley Chou; Mark M Urata; Harold Slavkin; Yang Chai
Journal:  Development       Date:  2006-01       Impact factor: 6.868

3.  Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via inhibition of the mevalonate pathway.

Authors:  Soheila Koohestanimobarhan; Siamak Salami; Vahideh Imeni; Zeinab Mohammadi; Omid Bayat
Journal:  J Cell Biochem       Date:  2018-09-06       Impact factor: 4.429

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

Review 5.  Should I stay or should I go? Cadherin function and regulation in the neural crest.

Authors:  Lisa A Taneyhill; Andrew T Schiffmacher
Journal:  Genesis       Date:  2017-03-20       Impact factor: 2.487

6.  The neural crest and cancer: a developmental spin on melanoma.

Authors:  Paul M Kulesa; Jason A Morrison; Caleb M Bailey
Journal:  Cells Tissues Organs       Date:  2013-06-15       Impact factor: 2.481

7.  miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.

Authors:  Haoxuan Zheng; Wenjing Li; Yadong Wang; Tingting Xie; Yidong Cai; Zhiqing Wang; Bo Jiang
Journal:  Carcinogenesis       Date:  2013-08-08       Impact factor: 4.944

8.  PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.

Authors:  Daisuke Fujimoto; Yuki Ueda; Yasuo Hirono; Takanori Goi; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-10-27

9.  TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.

Authors:  Gaia Cantelli; Jose L Orgaz; Irene Rodriguez-Hernandez; Panagiotis Karagiannis; Oscar Maiques; Xavier Matias-Guiu; Frank O Nestle; Rosa M Marti; Sophia N Karagiannis; Victoria Sanz-Moreno
Journal:  Curr Biol       Date:  2015-10-29       Impact factor: 10.834

10.  AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.

Authors:  Christophe Couderc; Alizée Boin; Laetitia Fuhrmann; Anne Vincent-Salomon; Vinay Mandati; Yann Kieffer; Fatima Mechta-Grigoriou; Laurence Del Maestro; Philippe Chavrier; David Vallerand; Isabelle Brito; Thierry Dubois; Leanne De Koning; Daniel Bouvard; Daniel Louvard; Alexis Gautreau; Dominique Lallemand
Journal:  Neoplasia       Date:  2016-01       Impact factor: 5.715

View more
  1 in total

1.  Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.

Authors:  Tiemo Sven Gerber; Dirk Andreas Ridder; Mario Schindeldecker; Arndt Weinmann; Diane Duret; Kai Breuhahn; Peter R Galle; Peter Schirmacher; Wilfried Roth; Hauke Lang; Beate Katharina Straub
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.